Invivyd
Jourdan Hourican is a Protein Analytics Research Associate at Invivyd since November 2023, previously serving as a Senior Research Associate and Research Associate at Agenus from October 2021 to August 2023. Prior experience includes a role as a Process Development Associate at the Broad Institute of MIT and Harvard from May 2021 to October 2021, and as a Molecular Diagnostics Research Intern at Brigham and Women's Hospital in early 2021. Earlier work at Boston Children's Hospital involved molecular diagnostic research in summer 2019, focusing on whole exams sequencing, PCR, and patient mutation analysis. Jourdan Hourican holds a Master’s degree in Bioinformatics from Endicott College, expected in May 2025, and a Bachelor's degree in Diagnostic Genetic Sciences, with a focus on Molecular Genetics, from the University of Connecticut, completed in 2021.
This person is not in any teams
This person is not in any offices
Invivyd
1 followers
Invivyd is a clinical-stage a biotechnology company developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional pre-emergent coronaviruses.